Target exploration in kinases and kinase inhibitors is an attractive area for drug development.

Our team has developed >100 assays covering Ser/Thr, Tyr and lipid kinases utilizing radiometric, fluorescence-based and luminescent readouts. Our integrated project teams have worked on many kinase targets across multiple therapeutic areas, delivering development candidates in inflammation, respiratory, metabolic and oncology indications.

In addition, our pioneering SoftFocus® kinase libraries have delivered outstanding success, leading to several development candidates.